Web Results

Acerus Pharmaceuticals Corporation - Home

www.aceruspharma.com/

Home · About Us · Our Company · Our Vision & Values · Leadership Team · Board of Directors · Technology · Products & Pipeline · ESTRACE® · NATESTO™  ...

Trimel Announces Closing of Exclusive Agreement for NATESTO(TM)

www.marketwired.com/press-release/trimel-announces-closing-of-exclusive-agreement-for-natesto-tsx-trl-1975138.htm

Dec 9, 2014 ... 9, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... agreement between its subsidiary, Trimel BioPharma SRL, and an affiliate of ...

Trimel Announces Exclusive License Agreement With Endo for ...

www.marketwired.com/press-release/trimel-announces-exclusive-license-agreement-with-endo-for-natesto-tsx-trl-1970983.htm

Nov 24, 2014 ... 24, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... Trimel Biopharma SRL, providing an affiliate of Endo International plc ...

Endo Pharmaceuticals Announces the Launch of NATESTO ...

www.prnewswire.com/news-releases/endo-pharmaceuticals-announces-the-launch-of-natesto-testosterone-nasal-gel-the-first-and-only-nasal-gel-for-testosterone-replacement-therapy-300050447.html

Mar 16, 2015 ... In 2014, Endo acquired the rights to NATESTO™ in the U.S. and Mexico from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel ...

Mattern Pharmaceuticals / The Nasal Company / News

mattern-pharma.com/news.php

The exclusive license rights MetP Pharma AG granted to Acerus associated with " Testosterone for women" have become in certain regions of the world ...

Endo Pharmaceuticals Shells Out 130 Million for Nearly 70 Pipeline ...

www.biospace.com/News/endo-pharmaceuticals-shells-out-130-million-for/376249

May 11, 2015 ... Endo acquired the rights to NATESTO in the U.S. and Mexico from Trimel BioPharma SRL, a subsidiary of Trimel Pharmaceuticals (TRL.TO), for ...

Label (PDF) - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2014/205488s000lbl.pdf

To report SUSPECTED ADVERSE REACTIONS, contact Trimel. BioPharma SRL at 1-844-Natesto (1-844-628-3786) or FDA at 1-800. FDA-1088 or ...

1 Reiner Schenk vs Valeant Pharmaceuticals International, Inc ...

www.redresssolutions.co.uk/wp-content/uploads/2015/09/Redress-makes-breakthrough-for-litigation-funding-in-Canada.pdf

SRL, Eugene Melnyk, Trimel Pharmaceuticals Corporation, Trimel Biopharma Inc , Trimel. Biopharma Holdings Inc. and Trimel Biopharma SRL,.

Efficacy and Safety of TBS-2 Testosterone Gel in Women With ...

clinicaltrials.gov/ct2/show/NCT01607658

May 18, 2012 ... Further study details as provided by Trimel Biopharma SRL: Primary Outcome Measures: change in the occurrence of orgasm over an 84 day ...

NCT01446042 - ClinicalTrials.gov

clinicaltrials.gov/ct2/show/NCT01446042

Sep 30, 2011 ... Further study details as provided by Trimel Biopharma SRL: Primary Outcome Measures: Serum testosterone Cavg [ Time Frame: 90 days ] ...

More Info

Trimel BioPharma | LinkedIn

www.linkedin.com

Trimel BioPharma Incorporated is now Trimel Pharmaceuticals Corporation. Trimel is a specialty pharmaceutical company actively developing medications for ...

Trivair Device: Home

www.trivairdevice.com

Dose is delivered. The turbulent flow has completely emptied the device. Privacy Statement|; Terms of Use. © 2016 by Acerus Pharmaceuticals SRL.

TriVair™ | Trivair Device

www.trivairdevice.com

In December 2009, Acerus Pharmaceuticals SRL (formerly Trimel BioPharma SRL), acquired the DirectHaler asset of Keldmann Healthcare A/S, which has ...